Advocacy intelligence hub — real-time data for patient organizations
Seoul National University Hospital — NA
Royal Devon and Exeter NHS Foundation Trust — NA
OnKure, Inc. — PHASE1
Pfizer — PHASE1
Medical College of Wisconsin — NA
Canadian Cancer Trials Group — PHASE2
Johns Hopkins University — NA
SWOG Cancer Research Network — PHASE3
Radiation Therapy Oncology Group — PHASE3
Ellence: FDA approved
Component of adjuvant therapy in patients with evidence of axillary node tumor involvement following resection of primary breast cancer.
Data from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.
FINANCIAL LANDSCAPE SUMMARY
Total programs
Open now
Copay cards
Copay Assistance8
Herceptin
Genentech
Herceptin Hylecta
Genentech
Eribulin Mesylate
Eisai
Tamoxifen Citrate
AstraZeneca
Paclitaxel protein-bound particles
Bristol Myers Squibb
Fareston
Orion
Halaven
Eisai
Ellence
Pfizer
Ellence
(Epirubicin)Orphan drugPharmacia & Upjohn Company
12.1 Mechanism of Action Epirubicin is an anthracycline cytotoxic agent. Although it is known that anthracyclines can interfere with a number of bioch...
Abraxane
(paclitaxel protein-bound particles)Orphan drugstandardAbraxis BioScience, LLC
Microtubule Inhibitor [EPC]
12.1 Mechanism of Action ABRAXANE is a microtubule inhibitor that promotes the assembly of microtubules from tubulin dimers and stabilizes microtubule...
Tamoxifen Citrate
(TAMOXIFEN CITRATE)Orphan drugstandardA-S Medication Solutions
Halaven
(eribulin mesylate)Orphan drugstandardEisai Inc.
12.1 Mechanism of Action Eribulin inhibits the growth phase of microtubules without affecting the shortening phase and sequesters tubulin into nonprod...
Taxol
(Paclitaxel)Orphan drugstandardBristol-Myers Squibb Pharmaceutical Research Institute
Microtubule Inhibitor [EPC]
Fareston
(Toremifene)Orphan drugstandardOrion Corporation
12.1 Mechanism of Action Toremifene is a nonsteroidal triphenylethylene derivative. Toremifene binds to estrogen receptors and may exert estrogenic, a...
Sandip P Patel
SWOG Cancer Research Network
📍 Birmingham, Alabama
Michael Heinrich, MD
Oregon Health and Science University
Mariana Chavez-MacGregor, MD, MSc
University of Alabama at Birmingham Cancer Center
📍 Birmingham, Alabama
Frank A. Vicini, MD, FACR
University of Alabama at Birmingham Cancer Center
📍 Birmingham, Alabama
Lucy Gates, PhD
Royal Devon University Healthcare NHS Foundation Trust
📍 Exeter, Devon
Chandler S Cortina
University of Southern California/Los Angeles (USC/LA County)
📍 Los Angeles, California